Osteoprotegerin (OPG) is a glycoprotein that acts as a decoy receptor for the receptor activator of nuclear factor kappa-Β ligand (RANKL), thereby inhibiting osteoclastogenesis and bone resorption. It plays a crucial role in the regulation of bone density and is implicated in various bone-related diseases and cardiovascular conditions.